Medical Marijuana, Inc. (OTC Pink: MJNA) is engaged as a cannabis and hemp company. Shares of the cannabis company gain 4.40%, through early trading on Tuesday, September 12, 2017. Over the past month, Medical Marijuana, Inc. saw average daily volume of 6.28 million shares. However, volume of 3.18 million shares or dollar volume of $275,706, has already exchanged hands on Tuesday.

Shares of Medical Marijuana, Inc. are rallying today, after the company announced that its two subsidiaries, Kannaway and HempMeds Mexico, have seen their largest sales month in corporate history, during August 2017. Furthermore, the company says they expect to launch another round of products during the fourth quarter. Here is the full press release detailing of the largest revenue month:

Medical Marijuana, Inc. Press Release:

SAN DIEGO, Sept. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that August 2017 was the Company’s largest revenue month in its history. Additionally, wholly-owned subsidiaries Kannaway® and HempMeds® Mexico experienced their largest months of revenue in their respective histories.

“Kannaway’s growth has been particularly stunning since it’s re-launch in March 2016,” said Kannaway CEO, Blake Schroeder. “Kannaway’s revenue has increased over 25 times during that time-period, and the company intends to launch a series of new products in Q4 2017 as it gears up for its regional convention this fall in Denver, Co. Additionally, there are plans to launch into Europe later this year. We fully expect Kannaway’s aggressive growth to continue!”

“As we continue to expand into new markets, we are proud to watch the Company achieve milestone after milestone,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our portfolio of companies continues to create exciting developments in the cannabidiol (CBD) sector. Medical Marijuana, Inc. and our portfolio of companies are on track for a banner year, in terms of gross sales revenue figures.”

“This increase in revenue is allowing us to further our research and development efforts – which is crucial to our longer-term shareholder valuation strategies,” continues Titus. “Over the past months we have been able to add some fantastic new additions to Kannaway’s product line and we look forward to continuing this leadership role within the industry.”

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

Add a Comment to this Post